D-tek s.a. is a private Belgian biotechnology company created in 1995 in Mons (40 km from Brussels and less than 1h20 from Paris). The company is located in 1.200 square meters facilities in the Scientific Park Initialis of Mons. The company is specialized in the development and manufacturing of diagnostic kits for human autoimmune diseases. Doctors generally distinguish systemic and organ-specific autoimmune diseases, depending if they affect multiple organs or only one organ specifically. The etiology of autoimmune diseases is clearly multifactorial. Both intrinsic factors (e.g. genetics, hormones, age) and environmental factors (e.g. infections, diet, drugs, and environmental chemicals) may contribute to the induction, development and progression of autoimmune diseases. The impressive range of products, their quality and the commitment to the customer’s satisfaction explain why D-tek’s products are now sold worldwide through a network of experienced distributors.
D-tek proposes a complete and comprehensive range of diagnostic kits for human autoimmune diseases. Indeed, D-tek produces ELISA, immunodot, microarrays and customized immundot. Additionnaly, D-tek proposes an automated platform from processing to interpretation steps : BlueDiver Instrument and Dr DOT software.
Research & development
Next to the innovative diagnostic products that are regularly brought to the market, D-tek is known for their openness to clinicians’ requests and their willingness to help them in their investigations. This approach has notably been consecrated by the launching of some unique and innovative Research Use Only kits.
Since its creation in 1995, D-tek is collaborating with other private companies, research centers and universities. D-tek notably proposes some unique and innovative range of liquid substrates, stabilizers, buffers and membrane devises. Additionally, D-tek opens to collaboration its technological platform BlueDiver Instrument and Dr Dot software.
Autoimmune diseases are due to inappropriate immune response against the organism’s own antigens (autoantigens), leading to chronic inflammation, tissue destruction and/or dysfunction. Generally unknown by the public and perceived as uncommon, they represent nevertheless the third cause of clinical mortality in industrialized countries.
According to the estimation of the World Health Organization, they affect up to 6 % of the global population. Scientists and doctors agree that more than 60 diseases have a proven or strongly suspected autoimmune cause. Moreover, there is epidemiological evidence of increasing prevalence of certain autoimmune diseases, which cannot be attributed to focus on or improvement of the diagnosis alone.
As the autoimmune diseases are generally incurable and require a lifelong treatment they have a strong impact on public health cost. Their accurate diagnosis has therefore become of major importance these last decades. All the diagnosis techniques available on the market are based on the ability to detect the presence of autoantibodies in the patient’s serum.
Thanks to its long experience in autoimmunity, its strong skills in Research and Development and its understanding of the customer’s needs, D-tek has developed an innovative range of diagnostic products. The know-how of D-tek has permitted the launching of more than 100 different kits on the market, many were a world première like the first kit for the detection of anti-Nucleosome (predictive marker of Lupus) antibody. Moreover, D-tek’s tremendous innovation capabilities have allowed the launching of new ranges : the BlueDiver Quantrix which are the first microarrays, quantitative and fully automated kits on nitrocellulose and the BlueDiver Combi which are the unique product that allows customization of the diagnostic test.